期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

半胱氨酸蛋白酶抑制剂C在急性冠状动脉综合征中的研究进展 被引量：3

Progress in Research for Cystatin C in Acute Coronary Syndrome
下载PDF
导出
摘要 半胱氨酸蛋白酶抑制剂C是评估肾小球滤过功能的一个理想指标,同时也参与了动脉粥样硬化的诸多病理生理过程。近年来半胱氨酸蛋白酶抑制剂C在冠心病发生发展中的作用受到越来越多的关注,其中半胱氨酸蛋白酶抑制剂C与急性冠状动脉综合征的研究资料不多,有关两者的关系需要更进一步的研究,以明确其作用的具体机制。现将半胱氨酸蛋白酶抑制剂C在急性冠状动脉综合征中的研究进展作一综述。 Cystatin C is an ideal biomarker for the assessment of glomerular filtration rate,and has also been shown to be involved in the pathophysiology of atherosclerosis.Due to its connection to atherosclerosis,cystatin C is garnering increased attention.Even so,there is still limited information about the connection between cystatin C and acute coronary syndrome(ACS).Further research is needed to clarify the specific mechanisms of cystatin C in ACS.This article reviews recent progress made in research connecting cystatin C to ACS.
作者 王喜梅 吴永健 杨跃进
机构地区 北京协和医学院中国医学科学院心血管病研究所阜外心血管病医院冠心病诊治中心
出处 《心血管病学进展》 CAS 2012年第3期297-299,共3页 Advances in Cardiovascular Diseases
关键词 半胱氨酸蛋白酶抑制剂C 急性冠状动脉综合征 cystatin C acute coronary syndrome
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献1

二级参考文献27

  • 1Adiguzel E, Ahmad PJ, Franco C, Bendeck MR Collagens in the progression and complications of atherosclerosis. Vasc Med 2009; 14: 73-89.
  • 2Rodriguez JA, Orbe J, Paramo JA. Metalloproteases, vascular remodeling and atherothrombotic syndromes. Rev Esp Cardiol 2007; 60: 959-967.
  • 3Punturieri A, Filippov S, Allen E, Caras I, Murray R, Reddy V, et al. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med 2000; 192: 789-799.
  • 4Sukhova GK, Shi GR Simon DI, Chapman HA, Libby R Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998; 102: 576-583.
  • 5Rodgers KJ, Watkins D J, Miller AL, Chan PY, Karanam S, Brissette WH, et al. Destabilizing role of cathepsin S in murine atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2006; 26: 851- 856.
  • 6Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GR Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 1359-1366.
  • 7Dubin G. Proteinaceous cysteine protease inhibitors. Cell Mol Life Sci 2005; 62: 653-669.
  • 8Shi GR Sukhova GK, Grubb A, Ducharme A, Rhode LH, Lee RT, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms. J Clin Invest 1999; 104: 1191-1197.
  • 9von Birgelen C, Klinkhart W, Mintz GS, Papatheodorou A, Herrmann J, Baumgart D, et al. Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo. J Am Coll Cardiol 2001 ; 37:1864-1870.
  • 10Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.

共引文献25

同被引文献33

  • 1冯娟,王宪.高同型半胱氨酸血症促进动脉粥样硬化发生发展的炎症免疫机制[J].中国医学前沿杂志（电子版）,2011,3(3):10-17. 被引量：30
  • 2Taglieri N, Kocnig W, Kaski JC. Cystatin C and cardiovascular risk [J]. Clinical Chemistry, 2009, 55(11): 1932-1943.
  • 3Aukrust P, Halvorsen B, Yndestad A, et al. Chemokines and cardio- vascular risk [J]. Arteriosclerosis, Thrombosis, and Vascular Biolo- gy, 2008, 28(11): 1909-1919.
  • 4Ferguson M A, Waiker S S. Established and emerging markers of kidney function. Clin Chem,2012,58 (4) :680-689.
  • 5Lassus J, Harjola V P. Cystatin-C:a step forward in assessing kidney function and cardiovascular risk. Heart Fail Rev, 2012, 17 ( 2 ) : 251-261.
  • 6Feng J F, Qiu L, Zhang L, et al. Multicenter study of creatinine- and/ or cystatin C-based equations for estimation of glomerular filtration rates in Chinese patients with chronic kidney disease. PLoS One, 2013,8 ( 3 ) : e57240.
  • 7Giamouzis G, Butler J, Triposkiadis F. Renal function in advanced heart failure. Congest Heart Fail,2011,17 (4) : 180-188.
  • 8Manzano-Femandz S, Januzzi J L, Boronat-Gareia M, et al. beta- trace protein and cystatin C as predictors of long-term outcomes in patients with acute heart failure. J Am CoB Cardiol,2011,57 (7) : 849 - 858.
  • 9Chaudhry S I, Mcavay G , Chen S, et al. Risk factors for hospital admission among older persons with newly diagnosed heart failure: findings from the Cardiovascular Health Study. J Am Coil Cardiol, 2013,61 (6) :635-642.
  • 10Braam B, Joles J A, Danishwar A H, et al. Cardiorenal syndrome- current understanding and future perspectives. Nat Rev Nephrol, 2014,10( 1 ) :48-45.

引证文献3

二级引证文献25

心血管病学进展
2012年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部